In a recent case highlighting the complexities of optic nerve disorders, a patient suffering from lymphoma experienced significant vision loss. Neuro-ophthalmologist Dr. Prem Subramanian was faced with the challenge of determining whether the cancer had infiltrated the optic nerve, the crucial pathway connecting the brain and eyes. Despite undergoing a series of tests—including blood work, MRI scans, and spinal taps—results remained inconclusive. The urgency of the situation escalated when the patient began to lose vision in the other eye, prompting Dr. Subramanian to make a difficult decision to perform a high-risk optic nerve biopsy.
“I did a full-thickness biopsy of the optic nerve, removing a piece of the optic nerve from the side that was connected to the already blind eye,” Dr. Subramanian explained. This procedure confirmed that lymphoma was affecting the patient’s optic nerve and allowed for timely treatment to preserve the remaining vision.
Optic nerve biopsies are typically viewed as a last resort due to their associated risks. Though, research published in 2025 from the Mayo Clinic indicates that these biopsies can be diagnostic, with 67% of 72 patients receiving a definitive diagnosis following the procedure. Dr. Subramanian, who contributed to this research, emphasized the importance of sharing this knowledge among medical professionals to improve understanding of when and how to conduct these biopsies effectively.
The Eye-Brain Connection
The optic nerve is a vital yet delicate structure in the visual pathway. It comprises over 1.1 million retinal ganglion cells, a type of neuron responsible for transmitting visual information from the retina to the brain. Damage to the optic nerve can lead to permanent vision loss, making the role of neuro-ophthalmologists like Dr. Subramanian critical.
Dr. Subramanian specializes in disorders of the optic nerve, such as inflammation, infection, and tumors. “A significant percentage of patients have tumors that cross between the orbit and the intracranial space, affecting vision and eye movement,” he noted. In cases where the cause of vision problems is unclear, a biopsy of the optic nerve or its sheath may be warranted.
Understanding Biopsy Techniques
Notice two primary types of biopsies: optic nerve biopsies and optic nerve sheath biopsies. The latter is generally less invasive and can be performed with a lower risk of damaging the optic nerve itself. The optic nerve sheath serves as a protective layer, similar to insulation on a wire. In certain conditions, this sheath can thicken, indicating potential disease.
When considering a biopsy, This proves crucial to evaluate whether the disease affects the sheath, the optic nerve, or both. Full-thickness biopsies involve cutting through the optic nerve entirely, which can lead to blindness in the connected eye. This option is usually reserved for patients who have already lost vision in that eye, allowing for a more strategic approach to preserving sight in the other eye.
Dr. Subramanian warns against performing inadequate biopsies, stating, “If you do a timid biopsy and only remove a small amount of tissue, you might as well not do it at all because you’re unlikely to receive a diagnosis from it.” The Mayo Clinic study found that full-thickness biopsies were more effective at securing a diagnosis compared to nerve sheath biopsies, with rates of 81% versus 55%, respectively.
Real-World Applications
Over his 25-year career, Dr. Subramanian has performed these biopsies fewer than ten times, underlining their rarity but also their potential impact. In one case, a patient suffering from progressive vision loss had previously undergone numerous tests without a clear diagnosis. After a failed steroid treatment, Dr. Subramanian conducted a biopsy that confirmed the presence of a tumor, enabling appropriate treatment to be initiated.
However, biopsy results are not always definitive. Dr. Subramanian recounted a case where a patient went blind in one eye and experienced vision loss in the other. The optic nerve biopsy on the blind eye revealed non-specific damage, leaving the underlying cause uncertain. Importantly, this biopsy helped rule out the presence of a malignant tumor, alleviating that concern for the patient.
Looking forward, Dr. Subramanian aims to advance research in genetic studies that could enhance diagnostic techniques for neuro-ophthalmologists. “These biopsies shouldn’t be done if you can get answers another way, but for the right patient, they can play a crucial role in preserving and protecting sight,” he emphasized.
This case underscores the intricate relationship between the eye and brain, highlighting the critical need for specialized care in diagnosing and treating optic nerve disorders. As ongoing research continues to inform best practices, patients may have more avenues to preserve their vision and navigate complex ocular health challenges.
For those interested in learning more about optic nerve biopsies and related research, consider discussing with your healthcare provider or consulting reputable medical sources.
Please remember that this article is for informational purposes only and is not a substitute for professional medical advice.
.png){kind=link}